Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.guficbio.com | |
Market Cap | 3,256.51 Cr. | |
Enterprise Value(EV) | 3,579.36 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 8.20 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 39.58 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 38.75 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 48.93 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 6.64 | Calculated using Price: 324.75 |
Dividend Yield | 0.03 | Period Ending 2023-03 |
No. of Shares Subscribed | 10.03 Cr. | 100,277,506 Shares |
FaceValue | 1 | |
About Gufic Biosciences Ltd. | ||
Gufic Biosciences Ltd. is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. |
1 Day |
|
-2.78% |
1 Week |
|
+8.05% |
1 Month |
|
+26.44% |
3 Month |
|
+8.12% |
6 Month |
|
+62.19% |
1 Year |
|
+51.70% |
2 Year |
|
+78.94% |
5 Year |
|
+280.50% |
10 Year |
|
+5702.68% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 15.60 | 23.99 | 25.31 | 36.03 | 33.89 | 22.17 | 29.22 | 43.31 | 25.84 | |
Return on Capital Employed (%) | 18.38 | 24.24 | 24.26 | 34.10 | 29.65 | 21.01 | 30.05 | 47.29 | 23.23 | |
Return on Assets (%) | 3.49 | 5.24 | 5.52 | 8.04 | 8.04 | 5.65 | 10.00 | 20.98 | 11.54 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 27 | 34 | 37 | 54 | 75 | 129 | 173 | 269 | 348 | 391 | |
Non Curr. Liab. | 17 | 15 | 9 | 13 | 17 | 38 | 55 | 66 | 224 | 201 | |
Curr. Liab. | 84 | 104 | 128 | 169 | 218 | 326 | 164 | 186 | 288 | 378 | |
Minority Int. | |||||||||||
Equity & Liab. | 127 | 152 | 175 | 235 | 310 | 493 | 392 | 521 | 860 | 969 | |
Non Curr. Assets | 36 | 33 | 31 | 37 | 46 | 134 | 131 | 201 | 396 | 458 | |
Curr. Assets | 91 | 120 | 143 | 198 | 264 | 359 | 261 | 321 | 464 | 511 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 127 | 152 | 175 | 235 | 310 | 493 | 392 | 521 | 860 | 969 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 152 | 202 | 246 | 306 | 351 | 379 | 488 | 779 | 691 | 760 | |
Other Income | 1 | 1 | 1 | 3 | 4 | 6 | 4 | 3 | 3 | 3 | |
Total Income | 152 | 203 | 247 | 308 | 355 | 385 | 491 | 782 | 693 | 763 | |
Total Expenditure | -137 | -183 | -223 | -267 | -305 | -327 | -404 | -631 | -556 | -620 | |
PBIDT | 15 | 20 | 24 | 42 | 50 | 58 | 88 | 151 | 137 | 143 | |
Interest | -4 | -6 | -6 | -9 | -10 | -14 | -14 | -5 | -8 | -14 | |
Depreciation | -4 | -4 | -4 | -4 | -5 | -14 | -16 | -19 | -22 | -19 | |
Taxation | -2 | -3 | -5 | -13 | -13 | -7 | -13 | -31 | -27 | -28 | |
Exceptional Items | 2 | ||||||||||
PAT | 4 | 7 | 9 | 16 | 22 | 23 | 44 | 96 | 80 | 82 | |
Adjusted EPS | 1 | 1 | 1 | 2 | 3 | 2 | 5 | 10 | 8 | 8 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 11 | 11 | -4 | -4 | -5 | 5 | 47 | 87 | 106 | -27 | |
Cash Fr. Inv. | -3 | -2 | -1 | -5 | -9 | -13 | -43 | -7 | -95 | -191 | |
Cash Fr. Finan. | -7 | -5 | 5 | 7 | 14 | 8 | -4 | -79 | -6 | 234 | |
Net Change | 1 | 4 | 0 | -1 | 1 | 0 | 0 | 2 | 5 | 17 | |
Cash & Cash Eqvt | 3 | 6 | 6 | 3 | 4 | 4 | 4 | 6 | 12 | 29 |
Fri, 24 Nov 2023
Analysts/Institutional Investor Meet/Con. Call Updates
|
|
Thu, 23 Nov 2023
Analysts/Institutional Investor Meet/Con. Call Updates
|
|
Fri, 17 Nov 2023
Investor Presentation
|
Fri, 01 Dec 2023 |
|
|
|
|
|